EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Long Non-Coding RNAs in Immune Thrombocytopenia: A Narrative Review of Pathogenesis and Potential Clinical Implications

Wojciech Homenda iD, Dominika Strzała iD, Aleksandra Połom iD, Rafał Moraczyński, Krzysztof Homenda iD, Sylwia Paszek iD, Natalia Potocka-Wojtowicz iD, Izabela Zawlik iD

Cells · 2026-11-05 · 15 (21) · 2018

DOI: 10.3390/cells15212018 ↗

At a glance

Übersichtsarbeit in Cells, published online on 2026-11-05. Written by Wojciech Homenda and 7 co-authors. Institution: Department of Nursing and Emergency Medicine, Pomeranian University, 76-200 Słupsk, Poland. Major MEDLINE topics: RNA, Long Noncoding, Purpura, Thrombocytopenic, Idiopathic. 143 references. The full text is freely available (open access, CC BY 4.0). Funded by: Pomeranian University in Slupsk.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background/Objectives: Immune thrombocytopenia (ITP) involves immune-mediated platelet destruction and impaired platelet production. Long non-coding RNAs (lncRNAs) regulate immune responses, but their clinical relevance in ITP remains uncertain. This narrative review examines disease-associated expression and mechanistic findings, distinguishing translational potential from established clinical utility.

Methods

English-language literature identified through PubMed, Scopus, and Google Scholar was synthesized narratively. Eight named lncRNAs were prioritized because the cited ITP studies provided transcript-specific patient data or functional evidence; exploratory expression profiling and evidence from other diseases were considered separately. Study design, sample size, specimen type, treatment exposure, and validation status informed interpretation.

Results

The selected transcripts were HCP5, NEAT1, lnc-DC, IFNG-AS1, MEG3, GAS5, MALAT1, and THRIL. Among the clinical studies with reported sample sizes, ITP groups generally included 20–90 patients, except for a GAS5 polymorphism study involving 302 patients. An independent prognostic association for low HCP5 expression was reported in a single study of 40 patients and has not been externally validated. Other studies described exploratory associations with bleeding, disease duration, or treatment response. Distinguishing primary from secondary ITP and selecting patients for splenectomy are not established applications. Cell experiments and a mouse model support mechanistic hypotheses but do not demonstrate therapeutic efficacy in humans.

Conclusions

The evidence supports biological plausibility and translational investigation, rather than routine diagnostic, prognostic, or treatment-guiding use. Prospective validation in clinically representative cohorts and standardized assays are required.

Subjects

MeSH terms (MEDLINE)

RNA, Long NoncodingPurpura, Thrombocytopenic, IdiopathicHumansAnimalsBlood Platelets

Author keywords

B cellsT cellsautoimmunitydiagnostic biomarkersgene regulationimmune thrombocytopenialong non-coding RNAsplateletstargeted therapies

Substances

RNA, Long Noncoding

Authors and institutions

  • Department of Nursing and Emergency Medicine, Pomeranian University, 76-200 Słupsk, Poland.
  • Department of Hematology and Bone Marrow Transplantation, Provincial Specialist Hospital, 76-200 Słupsk, Poland.
  • Doctoral School, Faculty of Health Sciences, Pomeranian University, 76-200 Słupsk, Poland.
  • Department of General Genetics, Faculty of Medicine, Collegium Medicum, University of Rzeszow, 35-959 Rzeszow, Poland.
  • Laboratory of Molecular Biology, Centre for Innovative Research in Medical and Natural Sciences, Collegium Medicum, University of Rzeszow, 35-959 Rzeszow, Poland.

ORCID profiles: Wojciech Homenda, Dominika Strzała, Aleksandra Połom, Krzysztof Homenda, Sylwia Paszek, Natalia Potocka-Wojtowicz, Izabela Zawlik

Funding

  • Pomeranian University in Slupsk

Cite

APA

Homenda, W., Strzała, D., Połom, A., Moraczyński, R., Homenda, K., Paszek, S., Potocka-Wojtowicz, N., & Zawlik, I. (2026). Long Non-Coding RNAs in Immune Thrombocytopenia: A Narrative Review of Pathogenesis and Potential Clinical Implications. Cells, 15(21), 2018. https://doi.org/10.3390/cells15212018

Vancouver

Homenda W, Strzała D, Połom A, Moraczyński R, Homenda K, Paszek S, et al. Long Non-Coding RNAs in Immune Thrombocytopenia: A Narrative Review of Pathogenesis and Potential Clinical Implications. Cells. 2026;15(21):2018. doi:10.3390/cells15212018

BibTeX
@article{Homenda2026,
  author = {Homenda, Wojciech and Strzała, Dominika and Połom, Aleksandra and Moraczyński, Rafał and Homenda, Krzysztof and Paszek, Sylwia and Potocka-Wojtowicz, Natalia and Zawlik, Izabela},
  title = {Long Non-Coding RNAs in Immune Thrombocytopenia: A Narrative Review of Pathogenesis and Potential Clinical Implications},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {2018},
  doi = {10.3390/cells15212018}
}
Start for free →